Compare PGEN & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | CRSR |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2013 | 2020 |
| Metric | PGEN | CRSR |
|---|---|---|
| Price | $5.55 | $8.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $8.33 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 5.5M | 4.3M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.37 |
| EPS | N/A | ★ 0.11 |
| Revenue | $230,981,000.00 | ★ $1,472,480,000.00 |
| Revenue This Year | $1,115.92 | N/A |
| Revenue Next Year | $81.04 | $6.90 |
| P/E Ratio | ★ N/A | $78.73 |
| Revenue Growth | N/A | ★ 11.86 |
| 52 Week Low | $1.40 | $4.48 |
| 52 Week High | $5.61 | $13.10 |
| Indicator | PGEN | CRSR |
|---|---|---|
| Relative Strength Index (RSI) | 74.63 | 50.71 |
| Support Level | $4.00 | $8.18 |
| Resistance Level | N/A | $13.10 |
| Average True Range (ATR) | 0.32 | 0.54 |
| MACD | 0.15 | -0.14 |
| Stochastic Oscillator | 96.70 | 42.08 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).